Anticancer CAS 183319 -69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HCl

China Anticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HCl, Find details about China Erlotinib, Erlotinib Hydrochloride from Anticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HCl

Model NO.
D-Sung Erlotinib
Product Name
Erlotinib Hydrochloride
Name
Erlotinib Hydrochloride Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anthelmintics
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAD No.
183319-69-9
Mf
C22h24cln3o4
Boiling Point
553.6 C at 760 Mmhg
Melting Point
223-225c
Stored Temperature
-20 C Freezer
Trademark
D-Sung
Transport Package
Negotiable
Specification
99%
Origin
Xi′an Shaanxi
Model NO.
D-Sung Erlotinib
Product Name
Erlotinib Hydrochloride
Name
Erlotinib Hydrochloride Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anthelmintics
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAD No.
183319-69-9
Mf
C22h24cln3o4
Boiling Point
553.6 C at 760 Mmhg
Melting Point
223-225c
Stored Temperature
-20 C Freezer
Trademark
D-Sung
Transport Package
Negotiable
Specification
99%
Origin
Xi′an Shaanxi
Anticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HCl
Anticancer CAS 183319-69-9 Erlotinib HCL Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib Hydrochloride
Product Description

Anticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HClAnticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HCl

Product Details

Anticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HCl

Product NameErlotinib Hydrochloride
AppearanceWhite Powder
CAD No.183319-69-9
MFC22H24ClN3O4
Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer.
Erlotinib hydrochloride should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Uses Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic
Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).
Application&Function

Anticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HCl

Erlotinib hydrochloride is a small molecule epidermal growth factor receptor tyrosine kinase reversible inhibitor, mainly used for second-line or third-line treatment of locally advanced or metastatic non-small cell lung cancer and the treatment of pancreatic cancer

Specification

Anticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HClAnticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HClAnticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HClAnticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HClAnticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HClAnticancer CAS 183319-69-9 Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride Powder Pharmaceutical Erlotinib HCl